Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events

Faculty Opinions recommendation of Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (canagliflozin cardiovascular assessment study).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732115060.793545344 ◽

2018 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Assessment Study ◽

Cardiovascular Assessment

Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular events

Cardiovascular Research ◽

10.1093/cvr/cvab121 ◽

2021 ◽

Author(s):

Bianca Rocca ◽

Karlheinz Peter

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Vascular Wall ◽

Therapeutic Targeting

Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events

Expert Review of Cardiovascular Therapy ◽

10.1080/14779072.2021.2020100 ◽

2021 ◽

Author(s):

Dario Calderone ◽

Salvatore Ingala ◽

Maria Sara Mauro ◽

Dominick J. Angiolillo ◽

Davide Capodanno

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Omega-3 Fatty Acid Supplementation in the Primary and Secondary Prevention of Cardiovascular Events

Journal of Cardiopulmonary Rehabilitation and Prevention ◽

10.1097/hcr.0000000000000608 ◽

2021 ◽

Vol 41 (3) ◽

pp. 137-140

Author(s):

Thomas F. O'Connell ◽

Justin Trivax ◽

Barry A. Franklin

Keyword(s):

Fatty Acid ◽

Secondary Prevention ◽

Cardiovascular Events ◽

Omega 3 ◽

Fatty Acid Supplementation ◽

Acid Supplementation ◽

Omega 3 Fatty Acid

Niacin for primary and secondary prevention of cardiovascular events

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd009744.pub2 ◽

2017 ◽

Cited By ~ 10

Author(s):

Stefan Schandelmaier ◽

Matthias Briel ◽

Ramon Saccilotto ◽

Kelechi K Olu ◽

Armon Arpagaus ◽

...

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis

Internal and Emergency Medicine ◽

10.1007/s11739-019-02204-2 ◽

2019 ◽

Vol 15 (1) ◽

pp. 135-143 ◽

Cited By ~ 3

Author(s):

Pasquale Pignatelli ◽

Alessio Farcomeni ◽

Danilo Menichelli ◽

Daniele Pastori ◽

Francesco Violi

Keyword(s):

Systematic Review ◽

Regression Analysis ◽

Secondary Prevention ◽

Serum Albumin ◽

Cardiovascular Events ◽

Observational Studies ◽

Meta Regression ◽

Meta Regression Analysis

Primary and secondary prevention of cardiovascular events through hormone replacement therapy

Wiener Medizinische Wochenschrift ◽

10.1007/s10354-005-0206-0 ◽

2005 ◽

Vol 155 (17-18) ◽

pp. 397-403

Author(s):

Heidemarie Pilz

Keyword(s):

Hormone Replacement Therapy ◽

Secondary Prevention ◽

Replacement Therapy ◽

Cardiovascular Events ◽

Hormone Replacement ◽

Is evolocumab a comparable alternative to statins in primary and secondary prevention of cardiovascular events in patients who cannot tolerate a statin?

Evidence-Based Practice ◽

10.1097/ebp.0000000000001160 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Author(s):

Robert Eberly ◽

Elizabeth Maldonado ◽

Kathleen Tilman

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Niacin for primary and secondary prevention of cardiovascular events

10.1002/14651858.cd009744 ◽

2012 ◽

Cited By ~ 1

Author(s):

Ramon Saccilotto ◽

Benjamin Kasenda ◽

Alain J Nordmann ◽

Matthias Briel

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events

Journal of Thrombosis and Thrombolysis ◽

10.1007/s11239-015-1307-2 ◽

2016 ◽

Vol 41 (3) ◽

pp. 493-504 ◽

Cited By ~ 1

Author(s):

Joonseok Kim ◽

Richard C. Becker

Keyword(s):

Secondary Prevention ◽

Cardiovascular Events ◽

Dosing Frequency